Quarterly report pursuant to Section 13 or 15(d)

Restructuring (Tables)

v3.23.1
Restructuring (Tables)
3 Months Ended
Mar. 31, 2023
Restructuring  
Summary of company's restructuring-related liability

    

    

Restructuring

    

Payments/

    

Charges

Utilization

Liability at

(Three Months Ended

(Three Months Ended

Liability at

    

December 31, 2022

    

March 31, 2023)

    

March 31, 2023)

    

March 31, 2023

Research and development contract termination costs

 

311,110

2,490

 

(313,600)

 

Other

 

4,922

 

4,237

 

(9,159)

 

Total Accrued restructuring

$

316,032

$

6,727

$

(322,759)

$